Merck ups outlook, turns profit during global vaccine hunt By LINDA A. JOHNSON - Associated Press Shares
Johnson and Johnson says human trials on coronavirus vaccine to start in July, not September By Shen Wu Tan and Tom Howell Jr. - The Washington Times Shares
Merck expects brunt of pandemic will strike this quarter By LINDA A. JOHNSON - Associated Press Shares
Merck to spin off assets with $6.5B in sales; 4Q profit up By LINDA A. JOHNSON - Associated Press Shares
Supreme Court sends dispute over Fosamax back to lower court By JESSICA GRESKO - Associated Press Shares
Merck 1Q net quadruples as cancer drug, vaccine sales soar By LINDA A. JOHNSON - Associated Press Shares
Companies, states interested in Louisiana hepatitis C plan By MELINDA DESLATTE - Associated Press Shares
Merck 4Q net powered by cancer treatment sales, lower taxes By LINDA A. JOHNSON - Associated Press Shares
High court seems likely to side with Merck in Fosamax case By JESSICA GRESKO - Associated Press Shares
Ebola spreads to major Congo city as vaccines a concern By CARLEY PETESCH and CARA ANNA - Associated Press Shares
FDA expands use of cervical cancer vaccine up to age 45 By LINDA A. JOHNSON - Associated Press Shares
Merck beats views on sales jumps for cancer drugs, vaccines By LINDA A. JOHNSON - Associated Press Shares
Congo approves use of experimental Ebola vaccine, WHO says By Tom Howell Jr. - The Washington Times Shares
